Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G04BD07	DETRUSITOL	B	Tolterodine (tartrate) - 2mg	2mg	Tablet, film coated	1,995,606 L.L
L01EB01	IRESSA	B	Gefitinib - 250mg	250mg	Tablet, fim coated	135,027,509 L.L
M01AE01	ADVIL LIQUI-GELS	B	Ibuprofen - 200mg	200mg	Capsule	464,970 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg	10mg	Capsule, hard	3,988,525 L.L
N06AB05	SEROXAT	B	Paroxetine (HCl) - 20mg	20mg	Tablet, film coated	1,586,205 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 420mg	420mg	Tablet, film coated	L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 125mg/5ml, Clavulanic Acid (potassium) - 31.25mg/5ml	156.25mg/5ml	Powder for suspension	302,365 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 20mg	20mg	Capsule, hard	7,634,958 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 15mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
C09AA05	TRITACE	B	Ramipril - 5mg	5mg	Tablet	509,316 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
G04BD08	VESICARE	B	Solifenacin succinate - 5mg	5mg	Tablet, film coated	1,619,330 L.L
M01AE01	BRUFEN	B	Ibuprofen - 100mg/5ml	100mg/5ml	Syrup	364,181 L.L
N02AA05	OXYNORM	B	Oxycodone HCl - 10mg/ml	10mg/ml	Injectable solution	1,584,390 L.L
A04AA02	KYTRIL	B	Granisetron (HCl) - 1mg	1mg	Tablet, film coated	2,765,628 L.L
A10BD09	INCRESYNC	B	Pioglitazone - 30mg, Alogliptin - 25mg		Tablet, film coated	3,897,143 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lipocream	221,734 L.L
J01CR02	AUGMENTIN	B	Amoxicillin (trihydrate) - 250mg/5ml, Clavulanic Acid (potassium) - 62.5mg/5ml	312.5mg/5ml	Powder for suspension	542,912 L.L
M01AE01	CHILDREN'S ADVIL	B	Ibuprofen - 100mg/5ml	100mg/5ml	Suspension	370,901 L.L
A10BD10	KOMBIGLYZE XR	B	Saxagliptin HCl - 2.5mg, Metformin HCl - 1000mg		Tablet, extended release	4,059,748 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	275,097,581 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lipocream	221,734 L.L
L02BX02	FIRMAGON	B	Degarelix (acetate) - 80mg	80mg	Injectable powder for solution+diluent	13,361,635 L.L
N02AA59	DOLOSPASMINE COMP	B	Codeine phosphate - 40 mg, Hexahydro-adipenine HCl - 50 mg, Propyphenazone - 500 mg		Suppository	267,489 L.L
A04AA02	KYTRIL	B	Granisetron (HCl) - 3mg/3ml	3mg/3ml	Injectable solution	3,711,693 L.L
A10BD10	KOMBIGLYZE XR	B	Saxagliptin HCl - 5mg, Metformin HCl - 1000mg		Tablet, extended release	3,979,118 L.L
B01AC27	UPTRAVI	B	Selexipag - 200mcg	200mcg	Tablet, film coated	613,462,617 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
L02BX02	FIRMAGON	B	Degarelix (acetate) - 120mg	120mg	Injectable powder for solution+diluent	24,325,802 L.L